Drug Approval | July 05, 2022
Sanofi flu vaccines licensed and approved for 2022-2023 influenza season
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
With the introduction of this device, Alkem is entering the core inhalation therapeutics and envisaging that the drug will reach the lungs effectively in each inhalation with added patient awareness and adherence programmes
Trelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated with less inhaler teaching time compared to other commonly used inhalers
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
Yashoda Hospitals Hyderabad has earned the distinction of becoming the first to introduce BTVA in India
Dupixent peak sales ambition raised to more than €13 billion
This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)
The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control
Subscribe To Our Newsletter & Stay Updated
